InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Vericel Corp

VCEL Clue Score63
United States Fiscal year ends December CIK 0000887359 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

20
Insider
Date
Role
Action
Shares
Price
Amount
Joseph Anthony Mara Jr
26 Jun 2026
Chief Financial Officer
Sold on a plan
5,000
$44.75
$223.75K
Jonathan Siegal
7 May 2026
Principal Accounting Officer
Sold on a plan
1,422
$40.50
$57.59K
Joseph Anthony Mara Jr
7 May 2026
Chief Financial Officer
Sold on a plan
5,000
$40.50
$202.50K
Jonathan Siegal
6 May 2026
Principal Accounting Officer
Sold on a plan
3,433
$38.00
$130.45K
Michael Halpin
2 Mar 2026
Chief Operating Officer
Sold on a plan
10,305
$35.30
$363.77K
Joseph Anthony Mara Jr
3 Mar 2025
Chief Financial Officer
Sold on a plan
9,000
$49.53
$445.77K
Jonathan Siegal
25 Feb 2025
Principal Accounting Officer
Sold on a plan
1,137
$52.07
$59.20K
Sean C. Flynn
25 Feb 2025
Chief Legal Officer
Sold on a plan
1,669
$52.07
$86.90K
Sean C. Flynn
20 Feb 2025
Chief Legal Officer
Sold on a plan
3,835
$57.32
$219.82K
Jonathan Siegal
19 Feb 2025
Principal Accounting Officer
Sold on a plan
1,710
$56.72
$96.99K
Jonathan Siegal
1 Oct 2024
Principal Accounting Officer
Sold on a plan
568
$41.90
$23.80K
Joseph Anthony Mara Jr
12 Jul 2024
Chief Financial Officer
Sold on a plan
5,000
$50.00
$250.00K
Jonathan Siegal
5 Jul 2024
Principal Accounting Officer
Sold on a plan
545
$45.00
$24.53K
Michael Halpin
11 Mar 2024
Chief Operating Officer
Sold on a plan
7,874
$44.71
$352.05K
Robert L Md Zerbe
25 Jan 2024
Director
Sold on a plan
200
$44.02
$8.80K
Robert L Md Zerbe
12 Jan 2024
Director
Sold on a plan
2,200
$38.09
$83.80K
Robert L Md Zerbe
15 Nov 2023
Director
Sold on a plan
100
$38.06
$3.81K
Robert L Md Zerbe
15 Nov 2023
Director
Sold on a plan
200
$38.00
$7.60K
Robert L Md Zerbe
14 Jul 2023
Director
Sold on a plan
1,000
$38.84
$38.84K
Robert L Md Zerbe
22 Jun 2023
Director
Sold on a plan
3,000
$36.00
$108.00K
Showing 250 of 265 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 342
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 20
Sales straight out of an exercise 173
Sales at will 27
Transactions with no price 0
Shares from compensation/vesting 3,203,734
Sales filed before the plan box existed 15
History held since 16 Oct 2006